We use cookies to understand how you use our site and to improve your experience.
This includes personalizing content and advertising.
By pressing "Accept All" or closing out of this banner, you consent to the use of all cookies and similar technologies and the sharing of information they collect with third parties.
You can reject marketing cookies by pressing "Deny Optional," but we still use essential, performance, and functional cookies.
In addition, whether you "Accept All," Deny Optional," click the X or otherwise continue to use the site, you accept our Privacy Policy and Terms of Service, revised from time to time.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Are Medical Stocks Lagging Auna S.A. (AUNA) This Year?
Read MoreHide Full Article
For those looking to find strong Medical stocks, it is prudent to search for companies in the group that are outperforming their peers. Has Auna S.A. (AUNA - Free Report) been one of those stocks this year? Let's take a closer look at the stock's year-to-date performance to find out.
Auna S.A. is a member of our Medical group, which includes 1010 different companies and currently sits at #2 in the Zacks Sector Rank. The Zacks Sector Rank gauges the strength of our 16 individual sector groups by measuring the average Zacks Rank of the individual stocks within the groups.
The Zacks Rank is a successful stock-picking model that emphasizes earnings estimates and estimate revisions. The system highlights a number of different stocks that could be poised to outperform the broader market over the next one to three months. Auna S.A. is currently sporting a Zacks Rank of #2 (Buy).
Within the past quarter, the Zacks Consensus Estimate for AUNA's full-year earnings has moved 3.3% higher. This means that analyst sentiment is stronger and the stock's earnings outlook is improving.
Based on the most recent data, AUNA has returned 27.1% so far this year. At the same time, Medical stocks have gained an average of 5.4%. This means that Auna S.A. is performing better than its sector in terms of year-to-date returns.
Another Medical stock, which has outperformed the sector so far this year, is BioNTech SE Sponsored ADR (BNTX - Free Report) . The stock has returned 7.8% year-to-date.
The consensus estimate for BioNTech SE Sponsored ADR's current year EPS has increased 1.4% over the past three months. The stock currently has a Zacks Rank #2 (Buy).
Looking more specifically, Auna S.A. belongs to the Medical Services industry, a group that includes 59 individual stocks and currently sits at #139 in the Zacks Industry Rank. This group has gained an average of 4.3% so far this year, so AUNA is performing better in this area.
BioNTech SE Sponsored ADR, however, belongs to the Medical - Biomedical and Genetics industry. Currently, this 510-stock industry is ranked #62. The industry has moved +13.5% so far this year.
Investors interested in the Medical sector may want to keep a close eye on Auna S.A. and BioNTech SE Sponsored ADR as they attempt to continue their solid performance.
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Image: Bigstock
Are Medical Stocks Lagging Auna S.A. (AUNA) This Year?
For those looking to find strong Medical stocks, it is prudent to search for companies in the group that are outperforming their peers. Has Auna S.A. (AUNA - Free Report) been one of those stocks this year? Let's take a closer look at the stock's year-to-date performance to find out.
Auna S.A. is a member of our Medical group, which includes 1010 different companies and currently sits at #2 in the Zacks Sector Rank. The Zacks Sector Rank gauges the strength of our 16 individual sector groups by measuring the average Zacks Rank of the individual stocks within the groups.
The Zacks Rank is a successful stock-picking model that emphasizes earnings estimates and estimate revisions. The system highlights a number of different stocks that could be poised to outperform the broader market over the next one to three months. Auna S.A. is currently sporting a Zacks Rank of #2 (Buy).
Within the past quarter, the Zacks Consensus Estimate for AUNA's full-year earnings has moved 3.3% higher. This means that analyst sentiment is stronger and the stock's earnings outlook is improving.
Based on the most recent data, AUNA has returned 27.1% so far this year. At the same time, Medical stocks have gained an average of 5.4%. This means that Auna S.A. is performing better than its sector in terms of year-to-date returns.
Another Medical stock, which has outperformed the sector so far this year, is BioNTech SE Sponsored ADR (BNTX - Free Report) . The stock has returned 7.8% year-to-date.
The consensus estimate for BioNTech SE Sponsored ADR's current year EPS has increased 1.4% over the past three months. The stock currently has a Zacks Rank #2 (Buy).
Looking more specifically, Auna S.A. belongs to the Medical Services industry, a group that includes 59 individual stocks and currently sits at #139 in the Zacks Industry Rank. This group has gained an average of 4.3% so far this year, so AUNA is performing better in this area.
BioNTech SE Sponsored ADR, however, belongs to the Medical - Biomedical and Genetics industry. Currently, this 510-stock industry is ranked #62. The industry has moved +13.5% so far this year.
Investors interested in the Medical sector may want to keep a close eye on Auna S.A. and BioNTech SE Sponsored ADR as they attempt to continue their solid performance.